Ticker > Company >

Wanbury share price

Wanbury Ltd.

NSE: WANBURY BSE: 524212 SECTOR: Pharmaceuticals & Drugs  31.12 K   19   2

259.20
+5.40 (2.13%)
BSE: 18 Sep 04:01 PM

Price Summary

Today's High

₹ 263.45

Today's Low

₹ 254.5

52 Week High

₹ 330

52 Week Low

₹ 155

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

852.17 Cr.

Enterprise Value

956.23 Cr.

No. of Shares

3.29 Cr.

P/E

19.82

P/B

11.69

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  22.16

CASH

5.9 Cr.

DEBT

109.95 Cr.

Promoter Holding

39.63 %

EPS (TTM)

₹  13.07

Sales Growth

15.21%

ROE

502.76 %

ROCE

61.61%

Profit Growth

392.42 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year15.21%
3 Year13.61%
5 Year8.02%

Profit Growth

1 Year392.42%
3 Year64.01%
5 Year26.38%

ROE%

1 Year502.76%
3 Year167.59%
5 Year100.55%

ROCE %

1 Year61.61%
3 Year95.18%
5 Year103.74%

Debt/Equity

5.2108

Price to Cash Flow

212.15

Interest Cover Ratio

2.0548

CFO/PAT (5 Yr. Avg.)

0.816163527878013

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 39.63 76.74
Mar 2025 39.76 76.74
Dec 2024 39.76 76.74
Sep 2024 39.77 76.74
Jun 2024 39.79 76.74
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 64.0077304360772% for the Past 3 years.
  • Company has been maintaining healthy ROE of 167.585933333333% over the past 3 years.
  • Company has been maintaining healthy ROCE of 95.182970832159% over the past 3 years.
  • Company’s PEG ratio is 0.0505639616508832.
  • The company has an efficient Cash Conversion Cycle of -119.5122 days.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 32.2050306774782.

 Limitations

  • The company has shown a poor revenue growth of 13.6141945309408% for the Past 3 years.
  • Company has high Debt to Equity ratio of 5.2108.
  • Company has contingent liabilities of 60.0385 Cr.
  • Tax rate is low at 1.2378.
  • Promoter pledging is high as 76.74%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 131.11 161.19 133.45 172 163.18
Total Expenditure 120.13 141.18 119.51 142.37 138.74
Operating Profit 10.97 20.01 13.95 29.63 24.44
Other Income 0.95 1.63 0.84 1.84 0.35
Interest 7.59 10.15 10.17 9.04 7.54
Depreciation 3.29 3.32 3.32 3.37 3.64
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.04 8.17 1.29 19.06 13.61
Tax 0 0.15 0.07 -1.2 0.12
Profit After Tax 1.04 8.02 1.22 20.26 13.49
Adjusted EPS (Rs) 0.32 2.45 0.37 6.18 4.1

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 367.45 392.52 511.19 499.65 575.65
Total Expenditure 389.07 376.85 479.45 476.57 505.65
Operating Profit -21.62 15.67 31.73 23.08 70
Other Income 46.2 4.75 5.09 1.01 2.99
Interest 32.87 23.07 20.61 21.39 29.18
Depreciation 9.68 9.75 11.45 12.38 13.03
Exceptional Items 82.64 0 76.37 -0.59 0
Profit Before Tax 64.67 -12.41 81.13 -10.29 30.78
Tax 0.21 0.2 -0.35 0.11 0.38
Net Profit 64.46 -12.61 81.47 -10.4 30.4
Adjusted EPS (Rs.) 25.79 -5.04 24.94 -3.18 9.28

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 25 25.02 32.67 32.71 32.75
Total Reserves -142.83 -155.67 -30.48 -39.96 -4.8
Borrowings 99.54 71.99 0 0 82
Other N/C liabilities 8.2 12.44 10.56 10.81 13.95
Current liabilities 283.89 328.19 332.62 292.84 214.11
Total Liabilities 273.8 281.97 345.37 296.4 337.99
Assets
Net Block 163.9 167.38 167.11 167.11 166.82
Capital WIP 13.89 11.01 2.35 1.61 3.01
Intangible WIP 0 0 0 0 0
Investments 0.01 0.01 0.01 0.01 0.03
Loans & Advances 3.8 3.4 3.8 5.03 5.42
Other N/C Assets 0.1 4.2 2.41 2.46 3.44
Current Assets 92.11 95.95 169.69 120.19 159.29
Total Assets 273.8 281.97 345.37 296.4 337.99
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 64.67 -12.41 81.13 -10.29 30.78
Adjustment -41.41 33.22 -43.68 37.01 41.61
Changes in Assets & Liabilities 20.9 -3 3.24 -6.75 -68.19
Tax Paid -0.03 -1.13 -0.16 -0.17 -0.18
Operating Cash Flow 44.13 16.68 40.52 19.8 4.02
Investing Cash Flow 63.66 8.04 0.59 -8.84 -16.63
Financing Cash Flow -107.87 -17.39 -28.58 -31.99 14.55
Net Cash Flow -0.09 7.34 12.53 -21.03 1.94

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 39.79 39.77 39.76 39.76 39.63
expert chemicals (india) ... 30.56 30.54 30.53 30.53 30.43
kingsbury investments inc... - - - - 9.20
kingsbury investments inc... 9.23 9.23 9.23 9.23 -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 60.21 60.23 60.24 60.24 60.37
authum investment and inf... 2.35 2.34 2.34 2.41 2.42
east eight six advisors l... 1.41 1.38 1.38 1.38 1.38
investor education and pr... 1.03 1.03 1.03 1.03 1.03
llp 1.55 1.62 1.67 1.73 1.71
magnum equifin private li... 1.53 1.53 1.53 1.53 1.52
milan manharkant ganatra 1.08 1.05 1.05 1.05 1.05
sharmin nasser - - - - 1.32
suresh bhatia 2.20 2.20 2.20 3.58 3.31
resonance opportunities f... - - - 1.22 -
surbhi investments and tr... 1.72 1.68 1.37 - -
suresh bhatia(huf) - - 1.08 - -
elizabeth mathew 1.13 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
Research Ventura

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Wanbury informs about press release 6 Aug, 11:17 AM Wanbury - Quaterly Results 4 Aug, 9:33 PM Wanbury - Quaterly Results 4 Aug, 9:33 PM Wanbury launches Iron supplement ‘C RED’ 27 Jun, 12:39 PM Wanbury gets GMP certificate for Patalganga facility 20 May, 11:43 AM Wanbury - Quaterly Results 15 May, 9:30 PM Wanbury - Quaterly Results 15 May, 9:30 PM Wanbury informs about updates 23 Apr, 12:08 PM Wanbury to launch two new products 24 Mar, 4:48 PM Wanbury informs about press release 6 Mar, 9:20 AM Wanbury - Quaterly Results 12 Feb, 8:45 PM Wanbury - Quaterly Results 12 Feb, 8:45 PM Wanbury completes Brazilian Health Authority audit at Tanuku plant facility 3 Jan, 3:59 PM Wanbury informs about press release 20 Dec, 2:09 PM Wanbury informs about press release 9 Sep, 9:38 AM Wanbury gets CEP for Dextromethorphan active pharmaceutical ingredient 9 Sep, 9:37 AM Wanbury informs about press release 23 Aug, 10:17 AM Wanbury gets EIR from USFDA for Maharashtra manufacturing facility 23 Aug, 10:12 AM Wanbury informs about updates 21 Aug, 3:12 PM Wanbury - Quaterly Results 12 Aug, 9:46 PM Wanbury - Quaterly Results 12 Aug, 9:46 PM Wanbury receives term loan facilities of Rs 60 crore from Tata Capital 27 Jun, 4:16 PM Wanbury informs about US FDA inspection 18 Jun, 2:18 PM USFDA completes inspection at Wanbury’s Patalganga site 18 Jun, 10:41 AM Wanbury - Quaterly Results 16 May, 7:26 PM Wanbury - Quaterly Results 16 May, 7:26 PM Wanbury informs about board meeting 7 May, 5:23 PM Wanbury informs about certificate 4 Apr, 5:24 PM Wanbury informs about completion of tenure of independent director 21 Feb, 2:10 PM Wanbury informs about press release 25 Jan, 5:16 PM Wanbury - Quaterly Results 24 Jan, 3:57 PM Wanbury - Quaterly Results 24 Jan, 3:57 PM Wanbury - Quaterly Results 24 Jan, 3:57 PM Wanbury informs about updates 15 Dec, 3:41 PM Wanbury informs about change in management 18 Nov, 3:46 PM Wanbury - Quaterly Results 20 Oct, 7:28 PM Wanbury - Quaterly Results 20 Oct, 7:28 PM Wanbury - Quaterly Results 7 Jul, 7:37 PM Wanbury - Quaterly Results 7 Jul, 7:37 PM Wanbury informs about closure of trading window 30 Dec, 5:07 PM Wanbury - Quaterly Results 28 Nov, 6:09 PM Wanbury - Quaterly Results 28 Nov, 6:09 PM Wanbury - Quaterly Results 28 Nov, 6:09 PM Wanbury - Quaterly Results 22 Jun, 7:17 PM Wanbury - Quaterly Results 22 Jun, 7:17 PM Wanbury - Quaterly Results 8 Feb, 4:13 PM Wanbury - Quaterly Results 8 Feb, 4:13 PM Wanbury - Quaterly Results 8 Feb, 4:13 PM Wanbury informs about closure of trading window 31 Dec, 2:00 PM Wanbury - Quaterly Results 25 Nov, 3:14 PM

Wanbury Stock Price Analysis and Quick Research Report. Is Wanbury an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Wanbury. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Wanbury has a PE ratio of 19.778505216141 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Wanbury has ROA of 9.5839% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Wanbury has a Current ratio of 0.744.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Wanbury has a ROE of 502.7578%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Wanbury has a Debt to Equity ratio of 5.2108 which means that the company has high proportion of debt in its capital.

  • Sales growth: Wanbury has reported revenue growth of 15.2113% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Wanbury for the current financial year is 12.1605531696528%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Wanbury is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Wanbury is Rs 13.0748. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Wanbury in Ticker for free. Also, one can get the intrinsic value of Wanbury by using Valuation Calculators, which are available with a Finology ONE subscription. 

Wanbury FAQs

Q1. What is Wanbury share price today?
Ans: The current share price of Wanbury is Rs 258.6.

Q2. What is the market capitalisation of Wanbury?
Ans: Wanbury has a market capitalisation of Rs 850.19916828 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Wanbury?
Ans: The PE ratio of Wanbury is 19.778505216141 and the P/B ratio of Wanbury is 11.6673584667304, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Wanbury share?
Ans: The 52-week high share price of Wanbury is Rs 329.7, and the 52-week low share price of Wanbury is Rs 154.01.

Q5. Does Wanbury pay dividends?
Ans: Currently, Wanbury does not pay dividends. Dividend yield of Wanbury is around 0%.

Q6. What are the face value and book value of Wanbury shares?
Ans: The face value of Wanbury shares is Rs 10, while the book value per share of Wanbury is around Rs 22.1644. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Wanbury?
Ans: Wanbury has a total debt of Rs 109.952 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Wanbury?
Ans: The ROE of Wanbury is 502.7578% and ROCE of Wanbury is 61.6081%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Wanbury a good buy for the long term?
Ans: The Wanbury long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Wanbury undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Wanbury appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Wanbury’s financials?
Ans: You can review Wanbury’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Wanbury
X